- Home
- WAI vs RANI Comparison
WAI vs RANI Comparison
Compare WAI & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- RANI
- Stock Information
- Founded
- WAI 2018
- RANI 2012
- Country
- WAI China
- RANI United States
- Employees
- WAI N/A
- RANI 140
- Industry
- WAI
- RANI Medicinal Chemicals and Botanical Products
- Sector
- WAI
- RANI Health Care
- Exchange
- WAI NYSE
- RANI Nasdaq
- Market Cap
- WAI 56.8M
- RANI 55.3M
- IPO Year
- WAI 2023
- RANI 2021
- Fundamental
- Price
- WAI $0.31
- RANI $1.66
- Analyst Decision
- WAI
- RANI Strong Buy
- Analyst Count
- WAI 0
- RANI 6
- Target Price
- WAI N/A
- RANI $11.33
- AVG Volume (30 Days)
- WAI 35.1K
- RANI 2.3M
- Earning Date
- WAI 03-04-2025
- RANI 03-19-2025
- Dividend Yield
- WAI N/A
- RANI N/A
- EPS Growth
- WAI N/A
- RANI N/A
- EPS
- WAI N/A
- RANI N/A
- Revenue
- WAI $3,989,698.00
- RANI N/A
- Revenue This Year
- WAI N/A
- RANI N/A
- Revenue Next Year
- WAI N/A
- RANI N/A
- P/E Ratio
- WAI N/A
- RANI N/A
- Revenue Growth
- WAI N/A
- RANI N/A
- 52 Week Low
- WAI $0.19
- RANI $1.24
- 52 Week High
- WAI $1.75
- RANI $8.75
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- RANI 54.80
- Support Level
- WAI N/A
- RANI $1.59
- Resistance Level
- WAI N/A
- RANI $1.90
- Average True Range (ATR)
- WAI 0.00
- RANI 0.15
- MACD
- WAI 0.00
- RANI 0.03
- Stochastic Oscillator
- WAI 0.00
- RANI 56.36
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides a number of essential business services in China to young and emerging companies including corporate business training services, which mainly focus on advanced knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising, and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.